Health & Fitness
Health and Fitness
Health and Fitness
Wed, March 28, 2012Tue, March 27, 2012Mon, March 26, 2012Sun, March 25, 2012Sat, March 24, 2012Fri, March 23, 2012Thu, March 22, 2012Wed, March 21, 2012Tue, March 20, 2012Mon, March 19, 2012Sun, March 18, 2012Fri, March 16, 2012Thu, March 15, 2012Wed, March 14, 2012Acura Pharmaceuticals to Present at the Needham Healthcare Conference on April 3, 2012
Published in Health and Fitness on Wednesday, March 21st 2012 at 4:07 GMT by Market Wire
March 21, 2012 07:00 ET
Acura Pharmaceuticals to Present at the Needham Healthcare Conference on April 3, 2012
PALATINE, IL--(Marketwire - Mar 21, 2012) - Acura Pharmaceuticals, Inc. (
During the presentation, material information concerning the Company, its operations, strategies and prospects may be discussed. A live webcast of the presentation will be available through the Investor page of Acura's website: [ www.acurapharm.com ]. An archived version of the presentation will be available for 30 days after the event.
Utilizing its proprietary AVERSION® and IMPEDE™ technologies, Acura develops products intended to address [ medication abuse and misuse ]. AVERSION contains polymers that cause the drug to gel when dissolved; it also contains compounds that irritate the nose. IMPEDE is designed to disrupt the processing of pseudoephedrine from tablets into methamphetamine.
About Acura Pharmaceuticals
Acura Pharmaceuticals is a specialty pharmaceutical company engaged in the research, development and commercialization of product candidates intended to address [ medication abuse and misuse ], utilizing its proprietary AVERSION and IMPEDE technologies. In June 2011, the U.S. Food and Drug Administration approved the first product incorporating the AVERSION technology. The Company has a development pipeline of additional AVERSION technology products and its IMPEDE technology for pseudoephedrine hydrochloride products.
